Abstract:Background: Fibroblast-like synoviocytes (FLS) are the prominent non-immune cells in synovium and play a pivotal role in rheumatoid arthritis (RA) pathogenesis. Cepharanthine (CEP), an alkaloid derived from Stephania cepharantha Hayata, has been reported to have anti-inflammatory, anti-tumor and immunomodulatory effects. However, its effects on RA FLS remain unclear. Objectives: To investigate the mechanisms of CEP in treating RA by targeting FLS. Methods: Proliferation of RA FLS was determined with CCK-8 while cell migration and invasion was assessed using a scratch wound assay and Transwell chambers, respectively. To determine transcriptional changes caused by CEP, bulk RNA sequencing (RNA-seq) was performed, followed by pathway enrichment and gene-set enrichment analysis. Cell cycle was assessed by flow cytometry. Metabolites in supernatants were measured by HPLC-MS, while cellular lipid reactive oxygen species (ROS) were tested by flow cytometry with BODIPY-C11 probing. Lipid peroxidation product 4-hydroxynonenal (4-HNE) in the conditioned media of FLS and in joints of collagen-induced arthritis were measured by ELISA and immunohistochemistry, respectively. E2F1 and NRF2 gene were knocked down with Lipofectamine and corresponding silencing RNAs. QPCR and Western blotting were applied to determine gene expression. Results: CEP inhibited the proliferation of RA FLS significantly in a dose-dependent manner and suppressed TNFα-induced migration and invasion. CEP caused significant changes to the gene expression in RA FLS and CEP-downregulated genes were related to cell cycle, glycolytic metabolism and citric acid cycle, etc. Consistently, CEP-treated RA FLS had a lower proportion of cells at S phase but a higher proportion of cells at G0/G1 phase. Expression levels of HIF-1α, PKM2, LDHA were downregulated, SIRT6 was upregulated by CEP, and levels of citric acid, lactate, and cis-aconitate in conditioned media were reduced by CEP. Transcription factor E2F1 was predicted to mediate the anti-proliferation, anti-migration, and metabolic modulation of CEP in RA FLS. In addition, NRF2 was the top transcription factor for CEP-upregulated genes. CEP could upregulate system Xc- (SLC7A11 and SLC3A2) by enhancing NRF2 expression. CEP decreased the production of lipid ROS and 4-HNE in RA FLS efficiently. Reduced 4-HNE level was also observed in the synovium from CEP-treated arthritis mice, along with alleviated synovial inflammation and joint destruction. Conclusion: Our results showed that CEP was able to restore inflammatory phenotypes of FLS, pointing to its use as an alternative agent for RA treatment. REFERENCES: NIL. Acknowledgements: NIL. Disclosure of Interests: None declared.

Cepharanthine Ameliorates Chondrocytic Inflammation and Osteoarthritis Via Regulating the MAPK/NF-κB-Autophagy Pathway

Cepharanthine Prevents Estrogen Deficiency-Induced Bone Loss by Inhibiting Bone Resorption

A molecular docking study: Cepharanthine protects articular cartilage against arthritis by Wnt/PI3K/TLR-3 signaling

Cell-free fat extract attenuates osteoarthritis via chondrocytes regeneration and macrophages immunomodulation

Caffeic acid phenethyl ester attenuates osteoarthritis progression by activating NRF2/HO‐1 and inhibiting the NF‐κB signaling pathway

AB0743 CEPHARANTHINE RESTORES FIBROBLAST-LIKE SYNOVIOCYTES FROM RHEUMATOID ARTHRITIS BY DIFFERENTIALLY REGULATING E2F1 AND NRF2 PATHWAYS

Schisandrin B Ameliorated Chondrocytes Inflammation and Osteoarthritis Via Suppression of NF-κB and MAPK Signal Pathways.

Cystathionine-γ-Lyase Attenuates Inflammatory Response and Pain of Osteoarthritis

Anti-arthritic effects of chlorogenic acid in interleukin-1β-induced rabbit chondrocytes and a rabbit osteoarthritis model.

Cepharanthine Suppresses Osteoclast Formation by Modulating the Nuclear Factor‐κb and Nuclear Factor of Activated T‐cell Signaling Pathways

Dapansutrile ameliorated chondrocyte inflammation and osteoarthritis through suppression of MAPK signaling pathway

Photo-crosslinked HAMA hydrogel with cordycepin encapsulated chitosan microspheres for osteoarthritis treatment.

Chicoric Acid Attenuates Tumor Necrosis Factor-Α-induced Inflammation and Apoptosis Via the Nrf2/HO-1, PI3K/AKT and NF-κB Signaling Pathways in C28/I2 Cells and Ameliorates the Progression of Osteoarthritis in a Rat Model.

Chondro-Protective Effects of Shikimic Acid on Osteoarthritis via Restoring Impaired Autophagy and Suppressing the MAPK/NF-κB Signaling Pathway

Calebin A modulates inflammatory and autophagy signals for the prevention and treatment of osteoarthritis

Pectolinarigenin targeting FGFR3 alleviates osteoarthritis progression by regulating the NF-κB/NLRP3 inflammasome pyroptotic pathway

Ceria Nanoparticles Alleviated Osteoarthritis Through Attenuating Senescence and Senescence-Associated Secretory Phenotype in Synoviocytes

Anemonin Attenuates Osteoarthritis Progression Through Inhibiting the Activation of IL-1β/ NF-Κb Pathway

Paeonol inhibits ACSL4 to protect chondrocytes from ferroptosis and ameliorates osteoarthritis progression

α-Cyperone (CYP) down-regulates NF-κB and MAPKs signaling, attenuating inflammation and extracellular matrix degradation in chondrocytes, to ameliorate osteoarthritis in mice

Nanomedicines Promote Cartilage Regeneration in Osteoarthritis by Synergistically Enhancing Chondrogenesis of Mesenchymal Stem Cells and Regulating Inflammatory Environment.